Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Withdrawn

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Status: Authorised

Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (25 July - 21 August 2025)

Start of procedure: Extension of marketing authorisation (25 July - 21 August 2025)

Agenda of the CVMP meeting 9-11 September 2025

Dossier administrative validation checklist for initial marketing authorisation applications by applicants

PSUSA/00002359/202501

Pre-submission request form for a EMA procedure prior to the submission of a marketing authorisation application or Article 58 Application

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes